EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Semaglutide and the Heart: Focus on Their Love–Hate Relationship

Ezaan Khan, Jessica Fernandes, Vishal Gohel, Rihi Jain, William Jayne, Colton Peck, Tara S. Shah, Radha S. Shah, Judithe LaBarge, Sidhartha D. Ray, Nilank Shah

Hearts · 24.07.2026 · 7 (3) · 22

DOI: 10.3390/hearts7030022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hearts, online erschienen am 24.07.2026. Verfasst von Ezaan Khan und 10 weiteren Autor:innen. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Semaglutide, a recombinant DNA-derived long-acting GLP-1 receptor agonist, has emerged as a key player for patients with or without T2DM and obesity. It exerts pleiotropic effects by modulating glycemic regulation and energy homeostasis. Mechanistically, it stimulates glucose-dependent insulin secretion and suppresses glucagon while enhancing satiety through POMC/NPY modulation in the arcuate nucleus and delaying gastric emptying. Beyond its metabolic utility, semaglutide is cardioprotective, leveraging the PI3K/Akt and eNOS pathways to improve vasodilation, reduce reactive oxygen species (ROS), and stabilize atherosclerotic plaques by inhibiting pro-inflammatory cytokines like TNF-α. While it improves cardiac output via PKA-mediated inotropy, potential cardiotoxicity, including resting tachycardia and autonomic-driven arrhythmias, requires clinical vigilance, particularly regarding electrolyte imbalances in heart failure patients. Ultimately, its robust vasculoprotective profile reinforces its potential as a cornerstone in cardiovascular pharmacotherapy. Further research is needed to better understand the effects of semaglutide on cardiac function and pathologies as it advances as a cardiac drug. This review discusses multiple molecular targets of semaglutide on the heart.

Zitieren

APA

Khan, E., Fernandes, J., Gohel, V., Jain, R., Jayne, W., Peck, C., Shah, T. S., Shah, R. S., LaBarge, J., Ray, S. D., & Shah, N. (2026). Semaglutide and the Heart: Focus on Their Love–Hate Relationship. Hearts, 7(3), 22. https://doi.org/10.3390/hearts7030022

Vancouver

Khan E, Fernandes J, Gohel V, Jain R, Jayne W, Peck C, et al. Semaglutide and the Heart: Focus on Their Love–Hate Relationship. Hearts. 2026;7(3):22. doi:10.3390/hearts7030022

BibTeX
@article{Khan2026,
  author = {Khan, Ezaan and Fernandes, Jessica and Gohel, Vishal and Jain, Rihi and Jayne, William and Peck, Colton and Shah, Tara S. and Shah, Radha S. and LaBarge, Judithe and Ray, Sidhartha D. and Shah, Nilank},
  title = {Semaglutide and the Heart: Focus on Their Love–Hate Relationship},
  journal = {Hearts},
  year = {2026},
  volume = {7},
  number = {3},
  pages = {22},
  doi = {10.3390/hearts7030022}
}
Kostenlos starten →